Chenghui Zhou

861 total citations · 1 hit paper
19 papers, 591 citations indexed

About

Chenghui Zhou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chenghui Zhou has authored 19 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chenghui Zhou's work include Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Chenghui Zhou is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Chenghui Zhou collaborates with scholars based in China, Germany and United States. Chenghui Zhou's co-authors include Christiane J. Bruns, Zhefang Wang, Qiongzhu Dong, Ningbo Fan, Yue Zhao, Fanyu Liu, Dai Li, Yongyi Bi, Thomas MacVicar and Yue Zhao and has published in prestigious journals such as Blood, The FASEB Journal and Annals of Oncology.

In The Last Decade

Chenghui Zhou

19 papers receiving 585 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

2021 220 citations Shun Wang, Yan Zheng et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenghui Zhou China	11	308	236	214	110	81	19	591
Margo P. Cain United States	6	389 1.3×	199 0.8×	236 1.1×	154 1.4×	98 1.2×	6	692
Guoxian Long China	15	289 0.9×	291 1.2×	217 1.0×	108 1.0×	45 0.6×	35	661
Hend Ahmed El-Hadaad Egypt	9	241 0.8×	243 1.0×	140 0.7×	105 1.0×	52 0.6×	25	552
Man Chu China	15	548 1.8×	255 1.1×	249 1.2×	99 0.9×	93 1.1×	19	767
Chengyong Dong China	17	387 1.3×	201 0.9×	251 1.2×	100 0.9×	103 1.3×	29	721
Songtao Lai China	11	314 1.0×	251 1.1×	168 0.8×	90 0.8×	105 1.3×	21	645
Shamir Cassim France	14	407 1.3×	149 0.6×	281 1.3×	104 0.9×	116 1.4×	17	696
Lanping Zhou China	15	362 1.2×	130 0.6×	166 0.8×	71 0.6×	55 0.7×	23	523
Eleonora Lai Italy	14	205 0.7×	315 1.3×	154 0.7×	145 1.3×	93 1.1×	46	572
Vijesh Kumar Yadav Taiwan	18	502 1.6×	173 0.7×	310 1.4×	147 1.3×	104 1.3×	41	814

Countries citing papers authored by Chenghui Zhou

Since Specialization

Citations

This map shows the geographic impact of Chenghui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghui Zhou more than expected).

Fields of papers citing papers by Chenghui Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghui Zhou. The network helps show where Chenghui Zhou may publish in the future.

Co-authorship network of co-authors of Chenghui Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghui Zhou. A scholar is included among the top collaborators of Chenghui Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghui Zhou. Chenghui Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ju, Feng, Jialei Weng, Ningbo Fan, et al.. (2025). AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5. Cell Death and Disease. 16(1). 483–483. 1 indexed citations

Li, Huili, et al.. (2024). Disulfidptosis: A new type of cell death. APOPTOSIS. 29(9-10). 1309–1329. 22 indexed citations

Zhou, Chenghui, Liqing Lu, Zhen Tang, et al.. (2023). The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients. BMC Gastroenterology. 23(1). 110–110. 1 indexed citations

Zhou, Chenghui, Zhefang Wang, Jiahui Li, et al.. (2021). Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification. Cancers. 13(10). 2403–2403. 20 indexed citations

Shi, Lin, Chenghui Zhou, Xiaoyan Long, et al.. (2021). 949P Thermal ablation plus toripalimab in patients with advanced hepatocellular carcinoma: Phase I results from a multicenter, open-label, controlled phase I/II trial (IR11330). Annals of Oncology. 32. S826–S826. 5 indexed citations

Zhou, Chenghui, et al.. (2021). Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma. Frontiers in Genetics. 12. 744113–744113. 11 indexed citations

Fan, Ningbo, Zhefang Wang, Chenghui Zhou, et al.. (2021). Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis. EClinicalMedicine. 42. 101183–101183. 16 indexed citations

Wang, Shun, Yan Zheng, Yang Feng, et al.. (2021). The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy. 6(1). 249–249. 220 indexed citations breakdown →

Zhou, Chenghui, Yiwei Zhang, Xi Hu, Min Fang, & Shuai Xiao. (2021). The effect of marital and insurance status on the survival of elderly patients with stage M1b colon cancer: a SEER-based study. BMC Cancer. 21(1). 891–891. 10 indexed citations

10.

Li, Jiahui, Xiao‐Lin Wu, Lars M. Schiffmann, et al.. (2021). IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. Cancers. 13(21). 5338–5338. 12 indexed citations

11.

Li, Jiarong, Hao Qin, Ling Liu, et al.. (2020). Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis. World Journal of Gastrointestinal Oncology. 12(10). 1195–1208. 10 indexed citations

12.

Wang, Zhefang, Fanyu Liu, Ningbo Fan, et al.. (2020). Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies. Frontiers in Oncology. 10. 589508–589508. 136 indexed citations

13.

Zhou, Chenghui, Ningbo Fan, Fanyu Liu, et al.. (2020). Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells. 9(6). 1481–1481. 28 indexed citations

14.

Zhou, Chenghui, Yu Chen, Wenying Kang, et al.. (2019). Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS/ERK signaling pathway. Journal of Molecular and Cellular Cardiology. 130. 23–35. 22 indexed citations

15.

Zhou, Chenghui & Nianfeng Li. (2019). [Expression of ZNF207 in hepatocellular carcinoma and its significance].. PubMed. 44(4). 406–412. 2 indexed citations

16.

Santos, Cédric Dos, Xiaochuan Shan, Chenghui Zhou, et al.. (2014). Anti-Leukemic Activity of Daratumumab in Acute Myeloid Leukemia Cells and Patient-Derived Xenografts. Blood. 124(21). 2312–2312. 12 indexed citations

17.

Shan, Xiaochuan, Cédric Dos Santos, Chenghui Zhou, et al.. (2014). Improved Patient-Derived Xenograft Model for Acute Myeloid Leukemia. Blood. 124(21). 3491–3491. 1 indexed citations

18.

Li, Yang, Baohua Wang, Chenghui Zhou, & Yongyi Bi. (2007). Matrine Induces Apoptosis in Angiotensin II‐Stimulated Hyperplasia of Cardiac Fibroblasts: Effects on Bcl‐2/Bax Expression and Caspase‐3 Activation. Basic & Clinical Pharmacology & Toxicology. 101(1). 1–8. 60 indexed citations

19.

Li, Yang, et al.. (2007). Matrine induces apoptosis in angiotensin II‐stimulated hyperplasia of cardiac fibroblasts: effects on Bcl‐2/Bax expression and caspase‐3 activation. The FASEB Journal. 21(6). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact